Taro Pharmaceutical Industries Ltd (TARO)
42.30
+0.10
(+0.24%)
USD |
NYSE |
May 17, 16:00
42.36
+0.06
(+0.14%)
After-Hours: 20:00
Taro Pharmaceutical Industries Accounts Receivable (Quarterly): 191.23M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 191.23M |
| September 30, 2023 | 181.06M |
| June 30, 2023 | 226.87M |
| March 31, 2023 | 202.26M |
| September 30, 2022 | 248.50M |
| June 30, 2022 | 265.86M |
| March 31, 2022 | 246.97M |
| December 31, 2021 | 224.67M |
| September 30, 2021 | 196.67M |
| June 30, 2021 | 216.83M |
| March 31, 2021 | 213.54M |
| December 31, 2020 | 228.82M |
| September 30, 2020 | 231.67M |
| June 30, 2020 | 189.30M |
| March 31, 2020 | 235.22M |
| December 31, 2019 | 227.33M |
| September 30, 2019 | 247.50M |
| June 30, 2019 | 213.51M |
| March 31, 2019 | 237.94M |
| December 31, 2018 | 223.79M |
| September 30, 2018 | 224.01M |
| June 30, 2018 | 209.14M |
| March 31, 2018 | 206.46M |
| December 31, 2017 | 197.80M |
| September 30, 2017 | 201.71M |
| Date | Value |
|---|---|
| June 30, 2017 | 185.88M |
| March 31, 2017 | 203.92M |
| December 31, 2016 | 251.62M |
| September 30, 2016 | 249.75M |
| June 30, 2016 | 289.80M |
| March 31, 2016 | 238.61M |
| December 31, 2015 | 279.54M |
| September 30, 2015 | 247.28M |
| June 30, 2015 | 196.80M |
| March 31, 2015 | 222.43M |
| December 31, 2014 | 225.65M |
| September 30, 2014 | 178.73M |
| June 30, 2014 | 103.53M |
| March 31, 2014 | 138.77M |
| December 31, 2013 | 127.01M |
| September 30, 2013 | 127.32M |
| June 30, 2013 | 116.60M |
| March 31, 2013 | 119.81M |
| December 31, 2012 | 134.59M |
| September 30, 2012 | 130.28M |
| June 30, 2012 | 120.24M |
| March 31, 2012 | 111.13M |
| December 31, 2011 | 120.83M |
| September 30, 2011 | 102.66M |
| June 30, 2011 | 83.14M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
181.06M
Minimum
Sep 2023
265.86M
Maximum
Jun 2022
221.55M
Average
225.77M
Median
Accounts Receivable (Quarterly) Benchmarks
| InspireMD Inc | 1.187M |
| BiomX Inc | -- |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -- |
| Holdco Nuvo Group DG Ltd | 0.04M |